Show simple item record

Enantiomer‐selective pharmacokinetics and metabolism of ketorolac in children

dc.contributor.authorKauffman, Ralph E.en_US
dc.contributor.authorLieh‐lai, Mary W.en_US
dc.contributor.authorUy, Herbert G.en_US
dc.contributor.authorAravind, M. K.en_US
dc.date.accessioned2015-01-07T15:24:28Z
dc.date.available2015-01-07T15:24:28Z
dc.date.issued1999-04en_US
dc.identifier.citationKauffman, Ralph E.; Lieh‐lai, Mary W. ; Uy, Herbert G.; Aravind, M. K. (1999). "Enantiomerâ selective pharmacokinetics and metabolism of ketorolac in children." Clinical Pharmacology & Therapeutics 65(4): 382-388.en_US
dc.identifier.issn0009-9236en_US
dc.identifier.issn1532-6535en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/110020
dc.publisherPediatric Research APS‐SPRen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titleEnantiomer‐selective pharmacokinetics and metabolism of ketorolac in childrenen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/110020/1/cptclpt1999381.pdf
dc.identifier.doi10.1016/S0009-9236(99)70131-1en_US
dc.identifier.sourceClinical Pharmacology & Therapeuticsen_US
dc.identifier.citedreferenceMaunuksela, E. L., PhD, Kokki, H., Bullingham, R. E. ( 1992 ). Comparison of intravenous ketorolac with morphine for postoperative pain in children. Clin Pharmacol Ther 52: 436 – 443.en_US
dc.identifier.citedreferenceMunro, H. M., Riegger, L. Q., Reynolds, P. I., Wilton, N. C., Lewis, I. H. ( 1994 ). Comparison of the analgesic and emetic properties of ketorolac and morphine for paediatric outpatient strabismus surgery. Br J Anaesth 72: 624 – 628.en_US
dc.identifier.citedreferenceGrisham, J., Vichinsky, E. (March 23–26, 1994 ). Ketorolac vs meperidine in vasooclusive crisis a study of safety and efficacy. Presented at the Nintheenth Annual Meeting of National Sickle Cell Disease, New York.en_US
dc.identifier.citedreferenceWatcha, M. F., Jones, M. B., Lagueruela, R. G., Schweiger, C., White, P. F. ( 1992 ). Comparison of ketorolac and morphine as adjuvants during pediatric surgery. Anesthesiology 76: 368 – 372.en_US
dc.identifier.citedreferencePurday, J. P., Reichert, C. C., Merrick, P. M. ( 1996 ). Comparative effects of three doses of intravenous ketorolac or morphine on emesis and analgesia for restorative dental surgery in children. Can J Anaesth 43: 221 – 225.en_US
dc.identifier.citedreferenceLieh‐Lai, M. W., Kauffman, R., Uy, H., Danjin, M., Simpson, P. ( 1996 ). Ketorolac for the treatment of severe pain in critically‐ill children. Pediatric Research APS‐SPR,: Washington, DC, 96/5/6.en_US
dc.identifier.citedreferenceVakily, M., Corrigan, B., Jamali, F. ( 1995 ). The problem of racemization in the stereospecific assay and pharmacokinetic evaluation of ketorolac in human and rats. Pharm Res 12: 1652 – 1657.en_US
dc.identifier.citedreferenceGonzalez‐Martin, G., Maggio, L., Gonzalez‐Sotomayor, J., Zuniga, S. ( 1997 ). Pharmacokinetics of ketorolac in children after abdominarl surgery. Int J Clin Pharmacol Ther 35: 160 – 163.en_US
dc.identifier.citedreferenceKerr, K. A., Banner, W., Pappas, J., Ahlquist, J. T. ( 1994 ). A pharmacokinetic study comparing intermittent vs. continuous infusion ketorolac in a pediatric intensive care unit (PICU).en_US
dc.identifier.citedreferenceOlkkola, K. T., Maunuksela, E. L. ( 1991 ). The pharmacokinetics of postoperative intravenous ketorolac tromethamine in children. Br J Clin Pharmacol 31: 182 – 184.en_US
dc.identifier.citedreferenceMroszczak, E. J., Lee, F. W., Combs, D., et al. ( 1987 ). Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans. Drug Metab Dispos 15: 618 – 626.en_US
dc.identifier.citedreferenceHayball, P. J., Wrobel, J., Tamblyn, J. G., Nation, R. L. ( 1994 ). The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate. Br J Clin Pharmacol 37: 75 – 78.en_US
dc.identifier.citedreferenceMroszczak, E., Combs, D., Chaplin, M., et al. ( 1996 ). Chiral kinetics and dynamics of ketorolac. J Clin Pharmacol 36: 521 – 539.en_US
dc.identifier.citedreferenceCarabaza, A., Cabre, F., Rotllan, E., et al. ( 1996 ). Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs. J Clin Pharmacol 36: 505 – 512.en_US
dc.identifier.citedreferenceLapicque, F., Muller, N., Payan, E., Dubois, N., Netter, P. ( 1993 ). Protein binding and stereoselectivity of nonsteroidal anti‐inflammatory drugs. Clin Pharmacokinet 25: 115 – 125.en_US
dc.identifier.citedreferenceHayball, P. J., Holman, J. W., Nation, R. L., Massy‐Westropp, R. A., Hamon, D. P. ( 1994 ). Marked enantioselective protein binding in humans of ketorolac in vitro: elucidation of enantiomer unbound fractions following facile synthesis and direct chiral HPLC resolution of tritium‐labelled ketorolac. Chirality 6: 642 – 648.en_US
dc.identifier.citedreferenceHayball, P. J., Holman, J. W., Nation, R. L. ( 1994 ). Influence of octanoic acid on the reversible protein binding of ketorolac enantiomers to human serum albumin (HSA): comparative liquid chromatographic studies using a HSA chiral stationary phase. J Chromatogr B Biomed Appl 662: 128 – 133.en_US
dc.identifier.citedreferenceBrocks, D. R., Jamali, F. ( 1992 ). Clinical pharmacokinetics of ketorolac tromethamine. Clin Pharmacokinet 23: 415 – 427.en_US
dc.identifier.citedreferenceGillis, J. C., Brogden, R. N. ( 1997 ). Ketorolac a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs 53: 139 – 188.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.